Naimish Patel
Children's National(US)
Publications by Year
Research Areas
Asthma and respiratory diseases, Allergic Rhinitis and Sensitization, Pneumocystis jirovecii pneumonia detection and treatment, Dermatology and Skin Diseases, Sinusitis and nasal conditions
Most-Cited Works
- → Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials(2019)1,406 cited
- → A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial(2014)438 cited
- → Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis(2022)422 cited
- → Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts(2023)421 cited
- → Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial(2020)370 cited
- → Cell Elasticity Determines Macrophage Function(2012)278 cited
- → Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial(2021)246 cited
- → Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial(2022)244 cited
- → Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation(2024)211 cited
- → Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials(2023)204 cited